Emerging research showed that patients with COVID-19 had 3.5 times the risk for developing Alzheimer’s disease and 2.6 times the risk for Parkinson’s disease in comparison to those who did not have COVID-19.
Patients who tested positive for COVID-19 had significantly elevated risks for developing Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and intracerebral hemorrhage in comparison to people who tested negative for COVID-19, according to the findings of a new study presented recently at the 8th European Academy of Neurology (EAN) Congress in Vienna, Austria.
In the study, which involved over 919,000 people in Denmark who were tested for COVID-19 between February 2020 and November 2021, 43,375 patients tested positive for COVID-19. Researchers found that patients with COVID-19 had 3.5 times the risk of developing Alzheimer’s disease, 2.6 times the risk of having Parkinson’s disease, 2.7 times the risk for suffering ischemic stroke and 4.8 times the risk of having intracerebral hemorrhage in comparison to patients who did not have COVID-19.
While previous research has noted an association between neurological disorders and COVID-19, lead study author Pardis Zarifkar, MD said the new study findings offer more clarity on the impact of COVID-19 on the incidence of neurological disease.
“These findings will help to inform our understanding of the long-term effect of COVID-19 on the body and the role that infections play in neurodegenerative diseases and stroke,” noted Dr. Zarifkar, who is affiliated with the Department of Neurology at Rigshospitalet in Copenhagen, Denmark.
(Editor's note: For a recent video interview with Pardis Zarifkar, MD, click here.)
The study authors also compared patients who tested positive for COVID-19 to patients with influenza or pneumonia and found similar elevated risks for the development of neurological diseases. However, when comparing COVID-19 to influenza and inpatients with pneumonia over the age of 80, the researchers noted a 1.7 times elevated risk of ischemic stroke for patients with COVID-19.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 2nd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.